Authors
Latest:
Costs Associated With Second-Line Therapies for Lung CancerErlotinib may confer an economic advantage for payers over docetaxel and pemetrexed for second-line treatment of lung cancer because of lower costs.
Latest:
Evaluating the Efficacy of Adjunctive Therapies Used to Treat COVID-19: The Role of Famotidine, Melatonin, and ThiamineH2-receptor antagonists, melatonin, and thiamine are some of the adjuvant treatments being evaluated for patients with COVID-19 due to their various immune-enhancing properties and possible antiviral effects.
Latest:
PQA Offers New CE Course on HIV Medication Use QualityPQA course provides an overview of how to build the best HIV treatment regimen and assess treatment outcomes.
Latest:
OTC, Prescription Drug Abuse Increasing Among AdolescentsNeighborhood pharmacists can provide support and information.
Latest:
Efficacy of Ezetimibe 2.5 mg With a Novel Tablet-Splitting StrategyThis prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.
Latest:
Is Pharmacy Going Green?Pharmacists are concerned about the proper disposal of medical waste, but is enough being done to be truly sustainable and green?
Latest:
Vaccine Collaboration: The Importance of Immunization PartnershipsVaccinations are among the most important preventive measures universally recommended by health authorities today.
Latest:
Droxidopa: Managing Neurogenic HypotensionThough clinically significant, NOH has had few treatment options.
Latest:
The Impact of 'Superutilizers' on Pharmacy SpendingPatients with multiple comorbid conditions siphon off a disproportionate share of health care dollars.
Latest:
A closer look at new FDA actionsMs. Domenici and Dr. Patel are both pharmacists at Brigham and Women's Hospital, Boston, Mass. Ms. Aiello is a sixth-year PharmD candidate from Massachusetts College of Pharmacy currently on clinical clerkship in the Investigational Drug Service at Brigham and Women's Hospital.
Latest:
Therapeutic and Subtherapeutic Dosing of Pregabalin: Medication Adherence, Healthcare Resource Utilization, and CostsTherapeutic and subtherapeutic doses of pregabalin were compared to ascertain differences in adherence, healthcare resource use, and cost between the cohorts.
Latest:
Punitive Damages Are Awarded Against Nursing HomeUnauthorized change in medication Is the subject of a case involving the death of an elderly patient.
Latest:
Evaluating Amantadine as a Potential Treatment for COVID-19Amantadine, a treatment that was originally used as an agent against influenza A, lost efficacy due to viral resistance.
Latest:
Free Drug Starter Programs Are Not All AlikeAlthough free drug starter programs are commonplace in the specialty pharmacy space, they vary widely in the marketplace.
Latest:
Chemotherapy and ObesityWhen giving antineoplastics to obese and morbidly obese patients, clinicians must be careful not to under- or overdose.
Latest:
Specialty Pharmacy: Where Patients are a Name, Not a NumberThe initial encounter between a patient and a specialty pharmacy is crucial to the long-term success of the partnership.
Latest:
Becoming a More Effective Pharmacy LeaderBeing effective may be the single most challenging tasks facing the pharmacy owner today.
Latest:
Reflections on the ASHP MidyearPharmacy Times Health-System Edition editor Stephen F. Eckel offers his thoughts on the American Society of Health-System Pharmacists Midyear Clinical Meeting.
Latest:
Precision Medicine and the Pharmacist’s Role as a Trusted Counselor in Specialty PharmacyThe placement of clinical pharmacists at the nexus of functional pharmacogenomics and in specialty pharmacy care makes good sense.
Latest:
As More Seniors Turn to At-Home Care, CMS Must Recognize Medical At-Home Pharmacy ServicesNearly half of community pharmacies offer long-term care services and play a critical role in ensuring patients have immediate access to medications in long-term care settings.
Latest:
Consolidation: Reshaping Pharmacy and BeyondThere is a concern that mergers and acquisitions in the pharmacy space will lead to decreased competition and loose agreements between companies that will not drive significant outcomes.
